CervoMed Inc. (CRVO)
NASDAQ·Healthcare·Biotechnology
$2.45
+0.41%
Mkt Cap $42.01M
Analyst Ratings
No recent rating data.
Price Target (7 analysts)
$9.00
Range $9.00 – $9.00
Implied Upside
+267.3%
Consensus $9.00 vs current $2.45
NASDAQ·Healthcare·Biotechnology
$2.45
+0.41%
Mkt Cap $42.01M
No recent rating data.
Price Target (7 analysts)
$9.00
Range $9.00 – $9.00
+267.3%
Consensus $9.00 vs current $2.45